TITLE

THE ENTITY OF BUERGER'S DISEASE

AUTHOR(S)
Inada, Kiyoshi; Katsumura, Tatsuki
PUB. DATE
December 1972
SOURCE
Angiology;Dec1972, Vol. 23 Issue 11, p668
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The entity and progression of occlusive lesion of thromboangiitis obliterans were discussed based on clinical experiences with 206 cases. The following conclusion were obtained: 1. Complete angiographic studies including translumbar aortography were performed routinely on every case except a few. Abnormalities in abdominal aorta and its major branches were rarely found in direct contrast to arteriosclerosis obliterans. 2. Operative findings performed on 55 cases, 61 limbs, suggest that progression of the occlusive changes in this disease was mainly due to secondary thrombosis although trigger mechanism is probably arteritis. 3. Buerger's disease is a separate entity different from arteriosclerosis obliterans although a patient with this disease is more susceptible to atherosclerosis than a normal person.
ACCESSION #
16358907

 

Related Articles

  • THROMBOANGIITIS OBLITERANS IN WOMEN. Hiertonn, T.; Lund, F.; Philipson, J. // Angiology;Jun1956, Vol. 7 Issue 3, p233 

    A case of thromboangiitis obliterans in a 43-year-old woman is described. Despite prolonged and intensive medication, the peripheral arterial insufficiency led to grave nutritional disturbances in the foot, including necrosis of the toes. Amputation above or possibly below the knee joint was...

  • BUERGER'S SYNDROME. Herman, Bernard E. // Angiology;Nov1975, Vol. 26 Issue 10, p713 

    All cases diagnosed as Buerger's disease at The Mount Sinai Hospital from 1933-1963 have been reviewed. A large majority were found to have well-known vascular problems other than what we now consider as Buerger's disease. Only two specimens from 33 amputations had the characteristic histologic...

  • Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Crowder, John E.; Cohn, Jay B.; Savitsky, J. Philip; Morgan, DeAnn L.; Slywka, Joseph; Cobert, Barton L.; Hryniewicki, Stephen W.; Piccirillo, Ronald T.; Wilcox, Charles S. // Angiology;Sep1989, Vol. 40 Issue 9, p795 

    The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up...

  • Buerger's Disease in Two Brothers: Iliac Artery Occlusion by Thromboangiitis Obliterans. Wysokinski, Waldemar E.; Kwiatkowska, Wieslawa; Maslowski, Leszek; Witkiewicz, Wojciech; Kowal-Gierczak, Barbara // Angiology;May1998, Vol. 49 Issue 5, p409 

    Several characteristics of thromboangiitis obliterans are unique and confirm the existence of the disease as a distinct pathological entity. Its predilection for young smoking males, peripheral type of vascular involvement, recurrences of superficial thrombophlebites, and typical...

  • Successful Intravenous Regional Sympathetic Blockade (Bier's Block) with Guanethidine and Lidocaine in a Patient with Advanced Buerger's Disease (Thromboangiitis Obliterans) A Case Report. Paraskevas, Kosmas I.; Trigka, Aikaterini A.; Samara, Maria // Angiology;Jul/Aug2005, Vol. 56 Issue 4, p493 

    A 65-year-old man, a heavy smoker with Buerger's disease (thromboangiitis obliterans), presented to this department with persistent severe ischemic rest pain at the fingers of his right hand, not responding to oral treatment with vasodilators and analgesics. Critical blood flow was discovered in...

  • Thromboangiitis Obliterans (Buerger's Disease): Searching for a Therapeutic Strategy. Paraskevas, Kosmas I.; Liapis, Christos D.; Briana, Despina D.; Mikhailidis, Dimitri P. // Angiology;Feb/Mar2007, Vol. 58 Issue 1, p75 

    Treatment of thromboangiitis obliterans (Buerger's disease) includes both surgical and nonsurgical approaches, or a combination of both. A definite therapeutic approach has not yet been set. This article reviews the proposed therapeutic strategies and considers the advantages and disadvantages...

  • The Prostacyclin Analog, Treprostinil Sodium, Provides Symptom Relief in Severe Buerger's Disease. Fernandez, Bernardo; Strootman, Deborah // Angiology;Jan/Feb2006, Vol. 57 Issue 1, p99 

    Buerger's disease (thromboangiitis obliterans or TAO) is a clinical syndrome characterized by the development of segmental thrombotic occlusions of the medium and small arteries. The primary treatment for Buerger's disease is cessation of cigarette smoking. In patients whose disease progresses...

  • Update on Thromboangiitis Obliterans (Buerger's Disease). Kirchner, Jeffrey T. // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1195 

    Presents a study by J.W. Olin on the current concepts of thromboangiitis obliterans, also known as Buerger's disease. Description of the study and its results; Effective treatment methods.

  • thromboangiitis obliterans. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p742 

    An encyclopedia entry for "thromboangiitis obliterans" is presented, which is also known as Buerger's disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics